Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2009 2
2010 3
2011 3
2012 1
2016 1
2017 2
2018 1
2019 2
2020 1
2021 2
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
Bassot A, Dragic H, Haddad SA, Moindrot L, Odouard S, Corlazzoli F, Marinari E, Bomane A, Brassens A, Marteyn A, Hibaoui Y, Petty TJ, Chalabi-Dchar M, Larrouquere L, Zdobnov EM, Legrand N, Tamburini J, Lincet H, Castets M, Yebra M, Migliorini D, Dutoit V, Walker PR, Preynat-Seauve O, Dietrich PY, Cosset É. Bassot A, et al. Among authors: castets m. Cell Death Dis. 2023 Sep 25;14(9):630. doi: 10.1038/s41419-023-06117-z. Cell Death Dis. 2023. PMID: 37749143 Free PMC article.
Targeting apoptosis in acute myeloid leukaemia.
Cassier PA, Castets M, Belhabri A, Vey N. Cassier PA, et al. Among authors: castets m. Br J Cancer. 2017 Oct 10;117(8):1089-1098. doi: 10.1038/bjc.2017.281. Epub 2017 Aug 24. Br J Cancer. 2017. PMID: 29017180 Free PMC article. Review.
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
Bertrand-Chapel A, Caligaris C, Fenouil T, Savary C, Aires S, Martel S, Huchedé P, Chassot C, Chauvet V, Cardot-Ruffino V, Morel AP, Subtil F, Mohkam K, Mabrut JY, Tonon L, Viari A, Cassier P, Hervieu V, Castets M, Mauviel A, Sentis S, Bartholin L. Bertrand-Chapel A, et al. Among authors: castets m. Commun Biol. 2022 Oct 7;5(1):1068. doi: 10.1038/s42003-022-03994-6. Commun Biol. 2022. PMID: 36207615 Free PMC article.
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.
Savary C, Luciana L, Huchedé P, Tourbez A, Coquet C, Broustal M, Lopez Gonzalez A, Deligne C, Diot T, Naret O, Costa M, Meynard N, Barbet V, Müller K, Tonon L, Gadot N, Degletagne C, Attignon V, Léon S, Vanbelle C, Bomane A, Rochet I, Mournetas V, Oliveira L, Rinaudo P, Bergeron C, Dutour A, Cordier-Bussat M, Roch A, Brandenberg N, El Zein S, Watson S, Orbach D, Delattre O, Dijoud F, Corradini N, Picard C, Maucort-Boulch D, Le Grand M, Pasquier E, Blay JY, Castets M, Broutier L. Savary C, et al. Among authors: castets m. Cell Rep Med. 2023 Dec 19;4(12):101339. doi: 10.1016/j.xcrm.2023.101339. Cell Rep Med. 2023. PMID: 38118405 Free PMC article.
The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.
Bisaccia J, Meyer S, Bertrand-Chapel A, Hecquet Q, Barbet V, Kaniewski B, Léon S, Gadot N, Rochet I, Fajnorova I, Leblond P, Cordier-Bussat M, Corradini N, Vasiljevic A, Billaud M, Picard C, Broutier L, Gallerne C, Dutour A, Blay JY, Castets M. Bisaccia J, et al. Among authors: castets m. Cell Death Discov. 2023 Jul 7;9(1):230. doi: 10.1038/s41420-023-01513-y. Cell Death Discov. 2023. PMID: 37414800 Free PMC article.
[Preventable cancers: Is it enough to change our behaviour?].
Billaud M, Castets M, Trautmann A, Sujobert P. Billaud M, et al. Among authors: castets m. Med Sci (Paris). 2023 May;39(5):452-457. doi: 10.1051/medsci/2023059. Epub 2023 May 23. Med Sci (Paris). 2023. PMID: 37219350 French.
30 results